TRIFLUCAN 40 mg/ml, powder for oral suspension bottle, 24.4 g
Active ingredients: Fluconazole
Commercialized according to BDPMDispensing in France: Prescription only
Powder for oral suspensionbottle, 24.4 gorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TRIFLUCAN 40 mg/ml, poudre pour suspension buvable
- Pharmaceutical form
- poudre pour suspension buvable
- Route of administration
- orale
- Presentation description
- 1 flacon(s) polyéthylène haute densité (PEHD) de 24,4 g avec seringue(s) pour administration orale avec adaptateur(s) pour flacon
- Marketing authorisation holder
- CRISTERS
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 14 May 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60877534CIP74900548CIP133400949005482Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| FLUCONAZOLEpoudre | 40 mg · 1 ml de suspension reconstituée | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.